Efficiency of Ipratropium Bromide and Albuterol Deposition in the Lung Delivered via a Soft Mist Inhaler or Chlorofluorocarbon Metered-Dose Inhaler. 2016

T R MacGregor, and R ZuWallack, and V Rubano, and M A Castles, and H Dewberry, and M Ghafouri, and C C Wood
Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA.

The propellant-free Combivent Respimat Soft Mist Inhaler (CVT-R) was developed to replace the chlorofluorocarbon-propelled Combivent metered-dose inhaler (CVT-MDI). This steady-state pharmacokinetic (PK) substudy evaluated drug lung-delivery efficiency, using data from two phase III safety and efficacy trials. PK parameters were obtained from well-controlled population PK analyses. Area under the plasma concentration-time curve (AUC), maximum observed plasma concentration (C(max)), and minimum observed plasma concentration (C(min)) showed systemic exposure to ipratropium bromide and albuterol delivered via the CVT-R was proportional to ex-mouthpiece delivered dose. Although the labeled dose of ipratropium bromide in the CVT-R was half that in the CVT-MDI, the systemic exposure was comparable. No PK interaction for the ipratropium bromide and albuterol Respimat drug components was demonstrated. Ipratropium bromide alone resulted in similar exposure to the combination of ipratropium bromide and albuterol. These results show that CVT-R delivers drug more efficiently to the lung than CVT-MDI.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D009241 Ipratropium A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic. N-Isopropylatropine,(endo,syn)-(+-)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane,Atrovent,Ipratropium Bromide,Ipratropium Bromide Anhydrous,Ipratropium Bromide Monohydrate,Ipratropium Bromide, (endo,anti)-Isomer,Ipratropium Bromide, (exo,syn)-Isomer,Ipratropium Bromide, endo-Isomer,Itrop,Sch-1000,Sch-1178,N Isopropylatropine,Sch 1000,Sch 1178,Sch1000,Sch1178
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000420 Albuterol A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. Salbutamol,2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol,Albuterol Sulfate,Proventil,Sultanol,Ventolin
D016001 Confidence Intervals A range of values for a variable of interest, e.g., a rate, constructed so that this range has a specified probability of including the true value of the variable. Confidence Interval,Interval, Confidence,Intervals, Confidence
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017402 Chlorofluorocarbons A series of hydrocarbons containing both chlorine and fluorine. These have been used as refrigerants, blowing agents, cleaning fluids, solvents, and as fire extinguishing agents. They have been shown to cause stratospheric ozone depletion and have been banned for many uses. Freons,Chlorofluorocarbon Derivatives,Freon,Derivatives, Chlorofluorocarbon

Related Publications

T R MacGregor, and R ZuWallack, and V Rubano, and M A Castles, and H Dewberry, and M Ghafouri, and C C Wood
August 2010, Respiratory medicine,
T R MacGregor, and R ZuWallack, and V Rubano, and M A Castles, and H Dewberry, and M Ghafouri, and C C Wood
August 2017, Journal of aerosol medicine and pulmonary drug delivery,
T R MacGregor, and R ZuWallack, and V Rubano, and M A Castles, and H Dewberry, and M Ghafouri, and C C Wood
March 2004, Pediatric pulmonology,
T R MacGregor, and R ZuWallack, and V Rubano, and M A Castles, and H Dewberry, and M Ghafouri, and C C Wood
January 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine,
T R MacGregor, and R ZuWallack, and V Rubano, and M A Castles, and H Dewberry, and M Ghafouri, and C C Wood
May 2005, European journal of clinical pharmacology,
T R MacGregor, and R ZuWallack, and V Rubano, and M A Castles, and H Dewberry, and M Ghafouri, and C C Wood
May 2000, Respiratory medicine,
T R MacGregor, and R ZuWallack, and V Rubano, and M A Castles, and H Dewberry, and M Ghafouri, and C C Wood
January 2000, Respiration; international review of thoracic diseases,
T R MacGregor, and R ZuWallack, and V Rubano, and M A Castles, and H Dewberry, and M Ghafouri, and C C Wood
January 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
T R MacGregor, and R ZuWallack, and V Rubano, and M A Castles, and H Dewberry, and M Ghafouri, and C C Wood
September 1992, British journal of clinical pharmacology,
T R MacGregor, and R ZuWallack, and V Rubano, and M A Castles, and H Dewberry, and M Ghafouri, and C C Wood
November 1994, The Journal of family practice,
Copied contents to your clipboard!